[Our data do not show a survival advantage for type 2 diabetes hemodialysis patients receiving RAS inhibiting therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine.
Gene-disease associations inferred from text-mining the literature.
DisGeNET evidence - LITERATURE